Crossmark

B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data

Crossref DOI link: https://doi.org/10.1186/s13643-018-0776-8

Published Online: 2018-07-31

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pufulete, Maria http://orcid.org/0000-0002-1775-1949
Maishman, Rachel

Dabner, Lucy

Higgins, Julian P. T.

Rogers, Chris A.

Dayer, Mark

MacLeod, John

Purdy, Sarah

Hollingworth, William

Schou, Morten

Anguita-Sanchez, Manuel

Karlström, Patric

Shochat, Michael Kleiner

McDonagh, Theresa

Nightingale, Angus K.

Reeves, Barnaby C.
Funding

Funding for this research was provided by:

Health Technology Assessment Programme (11-102-03)
License Information

Text and Data Mining valid from 2018-07-31
More Information

Article History

Received: 9 March 2018

Accepted: 16 July 2018

First Online: 31 July 2018

Ethics approval and consent to participate

: All original trials reported gaining the approval of an appropriate human ethics committee. The current analysis involves a secondary analysis of anonymised data; therefore, it does not require separate ethics committee approval.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below